Valeant Pharmaceuticals has added more cash to its offer to buy Botox maker Allergan in a bid that could now be worth more than $50 billion.
Source: Valeant raises cash-stock offer for Allergan
Valeant Pharmaceuticals has added more cash to its offer to buy Botox maker Allergan in a bid that could now be worth more than $50 billion.
Source: Valeant raises cash-stock offer for Allergan
No comments:
Post a Comment